Eli Lilly sues vendors accused of hawking versions of its experimental GLP-1

Eli Lilly said Wednesday it filed six lawsuits targeting wellness vendors who it said are selling illegal versions of its experimental weight-loss drug, retatrutide, in a bid to stem a flood of illicit online sales....

Redirecting to full article...